Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,819.75 +1.76 0.06%
FTSE 100 6,725.57 +2.51 0.04%
DAX 8,435.83 +37.83 0.45%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: NASDAQ GM
  • Sector: Diversified
  • Industry: Holding Companies-Divers
  • Sub-Industry: Diversified Operations

Horizon Pharma Inc

+ Add to Watchlist

HZNP:US

2.4000 USD 0.0100 0.41%

As of 20:10:00 ET on 05/17/2013.

Company Profile for Horizon Pharma Inc (HZNP)

Horizon Pharma, Inc., is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.

Contact Information

Horizon Pharma Inc

1033 Skokie Boulevard
Suite 355
Northbrook, IL 60062
United States
Phone: 1-224-383-3000
Fax: 1-224-383-3001

Key Executives for Horizon Pharma Inc (HZNP)

Timothy P WalbertChairman/President/CEORobert J De VaereExec VP/CFO/Secretary
Todd N SmithExec VP/Chief Commercial OfficerJeffrey W ShermanExec VP:Dev & Regulatory

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil